We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
Global study in approximately 180 adults with hidradenitis suppurativa to assess the efficacy and safety of two dose regimens of AVTX-009 compared to placeboTopline data expected in 2026 WAYNE...
WAYNE, Pa. and ROCKVILLE, Md., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2 | 2.10526315789 | 9.5 | 10.43 | 9 | 19288 | 9.64036781 | CS |
4 | 0.8 | 8.98876404494 | 8.9 | 10.43 | 8.3401 | 15655 | 9.44954529 | CS |
12 | -2.81 | -22.4620303757 | 12.51 | 13 | 6.84 | 18039 | 9.43163538 | CS |
26 | -5.06 | -34.2818428184 | 14.76 | 18.79 | 6.84 | 30782 | 12.28349148 | CS |
52 | -25.58 | -72.5056689342 | 35.28 | 45.096 | 3.9501 | 8216181 | 23.60692889 | CS |
156 | -518.3 | -98.1628787879 | 528 | 1711.2 | 3.9501 | 7939182 | 37.23740895 | CS |
260 | -679.1 | -98.5917537747 | 688.8 | 1711.2 | 3.9501 | 7654788 | 39.30816013 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions